[Experience gained with the drug amizon in the treatment of patients with mumps, with special reference to its effects on some biochemical markers].
Effectiveness was studied of a new drug amyzonum in a complex therapy of mumps in 149 patients versus the group of 177 patients having been treated with conventional methods only. A positive effect was shown of the drug on clinical indices, with the incidence of complications having gotten lower, biochemical indices having returned to normal.
Frolov
A F
AF
Frolov
V M
VM
Loskutova
I A
IA
Danilenko
V F
VF
Bukhtiarova
T A
TA
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers; D006801:Humans; D008297:Male; D009107:Mumps / Q000150:complications / Q000188:drug therapy*; D009824:Ointments; D009920:Orchitis / Q000188:drug therapy / Q000209:etiology; D009966:Orphenadrine / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy / Q000209:etiology; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D011726:Pyridinium Compounds
D000894:Anti-Inflammatory Agents, Non-Steroidal; D015415:Biomarkers; D009824:Ointments; D011725:Pyridines; D011726:Pyridinium Compounds; C410106:enisamium; D009966:Orphenadrine
Opyt primeneniia amizona v lechenii bol'nykh épidermicheskim parotitom i ego vliianie na nekotorye biokhimicheskie pokazateli.